Bleomycin	NN
induces	VBZ
molecular	JJ
changes	NNS
directly	RB
relevant	JJ
to	TO
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
:	:
a	DT
model	NN
for	IN
``	``
active	JJ
''	''
disease	NN
.	.

The	DT
preclinical	JJ
model	NN
of	IN
bleomycin-induced	JJ
lung	NN
fibrosis	NN
,	,
used	VBN
to	TO
investigate	VB
mechanisms	NNS
related	VBN
to	TO
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
,	,
has	VBZ
incorrectly	RB
predicted	VBN
efficacy	NN
for	IN
several	JJ
candidate	NN
compounds	NNS
suggesting	VBG
that	IN
it	PRP
may	MD
be	VB
of	IN
limited	JJ
value	NN
.	.

As	IN
an	DT
attempt	NN
to	TO
improve	VB
the	DT
predictive	JJ
nature	NN
of	IN
this	DT
model	NN
,	,
integrative	JJ
bioinformatic	JJ
approaches	NNS
were	VBD
used	VBN
to	TO
compare	VB
molecular	JJ
alterations	NNS
in	IN
the	DT
lungs	NNS
of	IN
bleomycin-treated	JJ
mice	NNS
and	CC
patients	NNS
with	IN
IPF	NN
.	.

Using	VBG
gene	NN
set	NN
enrichment	NN
analysis	NN
we	PRP
show	VBP
for	IN
the	DT
first	JJ
time	NN
that	WDT
genes	NNS
differentially	RB
expressed	VBN
during	IN
the	DT
fibrotic	JJ
phase	NN
of	IN
the	DT
single	JJ
challenge	NN
bleomycin	NN
model	NN
were	VBD
significantly	RB
enriched	JJ
in	IN
the	DT
expression	NN
profiles	NNS
of	IN
IPF	NN
patients	NNS
.	.

The	DT
genes	NNS
that	WDT
contributed	VBD
most	RBS
to	TO
the	DT
enrichment	NN
were	VBD
largely	RB
involved	VBN
in	IN
mitosis	NN
,	,
growth	NN
factor	NN
,	,
and	CC
matrix	NN
signaling	NN
.	.

Interestingly	RB
,	,
these	DT
same	JJ
mitotic	JJ
processes	NNS
were	VBD
increased	VBN
in	IN
the	DT
expression	NN
profiles	NNS
of	IN
fibroblasts	NNS
isolated	VBN
from	IN
rapidly	RB
progressing	VBG
,	,
but	CC
not	RB
slowly	RB
progressing	VBG
,	,
IPF	NN
patients	NNS
relative	JJ
to	TO
control	JJ
subjects	NNS
.	.

The	DT
data	NNS
also	RB
indicated	VBD
that	IN
TGFb	NN
was	VBD
not	RB
the	DT
sole	JJ
mediator	NN
responsible	JJ
for	IN
the	DT
changes	NNS
observed	VBN
in	IN
this	DT
model	NN
since	IN
the	DT
ALK-5	NN
inhibitor	NN
SB525334	NN
effectively	RB
attenuated	VBD
some	DT
but	CC
not	RB
all	DT
of	IN
the	DT
fibrosis	NN
associated	VBN
with	IN
this	DT
model	NN
.	.

Although	IN
some	DT
would	MD
suggest	VB
that	IN
repetitive	JJ
bleomycin	NN
injuries	NNS
may	MD
more	RBR
effectively	RB
model	JJ
IPF-like	JJ
changes	NNS
,	,
our	PRP$
data	NNS
do	VBP
not	RB
support	VB
this	DT
conclusion	NN
.	.

Together	RB
,	,
these	DT
data	NNS
highlight	VBP
that	IN
a	DT
single	JJ
bleomycin	NN
instillation	NN
effectively	RB
replicates	VBZ
several	JJ
of	IN
the	DT
specific	JJ
pathogenic	JJ
molecular	JJ
changes	NNS
associated	VBN
with	IN
IPF	NN
,	,
and	CC
may	MD
be	VB
best	RB
used	VBN
as	IN
a	DT
model	NN
for	IN
patients	NNS
with	IN
active	JJ
disease	NN
.	.

